Literature DB >> 18668554

Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator.

Yoshihiro Oya1, Norihiko Watanabe, Takayoshi Owada, Mie Oki, Koichi Hirose, Akira Suto, Shin-Ichiro Kagami, Hiroshi Nakajima, Takashi Kishimoto, Itsuo Iwamoto, Theresa L Murphy, Kenneth M Murphy, Yasushi Saito.   

Abstract

OBJECTIVE: B and T lymphocyte attenuator (BTLA), a coreceptor expressed on lymphocytes, was recently described as an inhibitory coreceptor that negatively regulates lymphocyte activation. The purpose of this study was to investigate the role of BTLA in the regulation of immune homeostasis and the pathogenesis of autoimmunity.
METHODS: We examined the levels of immunoglobulins and autoantibodies to nuclear antigens and the activation status of T cells in BTLA(-/-) mice. We also examined histopathologic changes in the organs of BTLA(-/-) mice.
RESULTS: We observed that BTLA(-/-) mice gradually developed hypergammaglobulinemia, antinuclear antibodies, anti-SSA antibodies, anti-double-stranded DNA antibodies, and an increased number of activated CD4+ T cells in the periphery with age. Lack of BTLA led to spontaneous development of autoimmune hepatitis-like disease characterized by an elevation in the level of transaminases, interface hepatitis, and spotty necrosis of the liver. BTLA(-/-) mice also showed inflammatory cell infiltration of multiple organs, including the salivary glands, lungs, and pancreas; these features are similar to those of Sjögren's syndrome, which is a frequent complication of autoimmune hepatitis. Furthermore, the survival rate of BTLA(-/-) mice was significantly reduced after the age of 7 months.
CONCLUSION: Our results indicate that BTLA plays an important role in the maintenance of immune tolerance and the prevention of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668554      PMCID: PMC2782777          DOI: 10.1002/art.23674

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  41 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  Albert J Czaja; Deborah K Freese
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

3.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

4.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

5.  Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.

Authors:  Y Qian; C Santiago; M Borrero; T F Tedder; S H Clarke
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 6.  T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens.

Authors:  H R MacDonald; R Schneider; R K Lees; R C Howe; H Acha-Orbea; H Festenstein; R M Zinkernagel; H Hengartner
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

7.  Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.

Authors:  Keiko Matsumoto; Norihiko Watanabe; Bunshiro Akikusa; Kazuhiro Kurasawa; Ryutaro Matsumura; Yasushi Saito; Itsuo Iwamoto; Takashi Saito
Journal:  Arthritis Rheum       Date:  2003-02

8.  Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

9.  Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver.

Authors:  Harmeet Malhi; Pallavi Annamaneni; Sanjeev Slehria; Brigid Joseph; Kuldeep K Bhargava; Christopher J Palestro; Phyllis M Novikoff; Sanjeev Gupta
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Authors:  Norihiko Watanabe; Maya Gavrieli; John R Sedy; Jianfei Yang; Francesca Fallarino; Susan K Loftin; Michelle A Hurchla; Natalie Zimmerman; Julia Sim; Xingxing Zang; Theresa L Murphy; John H Russell; James P Allison; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

View more
  52 in total

Review 1.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

2.  Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits.

Authors:  Verónica C Martínez Allo; Vanesa Hauk; Nicolas Sarbia; Nicolás A Pinto; Diego O Croci; Tomás Dalotto-Moreno; Rosa M Morales; Sabrina G Gatto; Montana N Manselle Cocco; Juan C Stupirski; Ángel Deladoey; Esteban Maronna; Priscila Marcaida; Virginia Durigan; Anastasia Secco; Marta Mamani; Alicia Dos Santos; Antonio Catalán Pellet; Claudia Pérez Leiros; Gabriel A Rabinovich; Marta A Toscano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

3.  BTLA associates with increased Foxp3 expression in CD4(+) T cells in dextran sulfate sodium-induced colitis.

Authors:  Han-Xian Zhang; Bin Zhu; Xiao-Xia Fu; Jin-Cheng Zeng; Jun-Ai Zhang; Wan-Dang Wang; Bin Kong; Wen-Yu Xiang; Jixin Zhong; Cong-Yi Wang; Xue-Bao Zheng; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.

Authors:  Jose-Ignacio Rodriguez-Barbosa; Carlos Fernandez-Renedo; Ana María Bravo Moral; Leo Bühler; Maria-Luisa Del Rio
Journal:  Cell Mol Immunol       Date:  2016-02-29       Impact factor: 11.530

5.  Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.

Authors:  Yukimi Sakoda; Jang-June Park; Yuming Zhao; Atsuo Kuramasu; Degui Geng; Yingjia Liu; Eduardo Davila; Koji Tamada
Journal:  Blood       Date:  2011-01-10       Impact factor: 22.113

6.  Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype.

Authors:  Xiaobin Tang; Linjie Tian; Gloria Esteso; Seung-Chul Choi; Alexander D Barrow; Marco Colonna; Francisco Borrego; John E Coligan
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

Review 7.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

8.  CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.

Authors:  Marie-Laure Thibult; Jean-Paul Rivals; Emilie Mamessier; Julie Gertner-Dardenne; Sonia Pastor; Daniel E Speiser; Laurent Derré; Daniel Olive
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

9.  B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.

Authors:  Yoshihisa Kobayashi; Arifumi Iwata; Kotaro Suzuki; Akira Suto; Saki Kawashima; Yukari Saito; Takayoshi Owada; Midori Kobayashi; Norihiko Watanabe; Hiroshi Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 10.  Novel antibodies targeting immune regulatory checkpoints for cancer therapy.

Authors:  Chern Siang Lee; Mark Cragg; Martin Glennie; Peter Johnson
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.